Conference Coverage
Conference Coverage
Stem Cell Transplant Boosts Survival in Scleroderma
Major Finding: Death or persistent major organ failure during an average 7 years of follow-up occurred in 19 patients with poor-prognosis diffuse...
Conference Coverage
Rosuvastatin Lessened Endothelial Dysfunction in SSc
Major finding: Rosuvastatin increased low-mediated dilatation in systemic sclerosis from 2.3% to 5.7%.Data source: The data come from a case-...
Conference Coverage
Add-On Glargine Bests Sitagliptin for Regaining Glucose Control
Major Finding: Hemoglobin A1c, 8.5% for both groups at baseline, was reduced to a significantly greater extent with insulin glargine than with...
Conference Coverage
Primary Care Rivals Specialists on Apnea Management
Major Finding: Epworth Sleepiness Scale scores improved 4.9 points after 6 months of primary care management of OSA; they improved a mean of 5.1...
Conference Coverage
Ziana Proves Less Irritating Than Epiduo for Acne
Major Finding: Transepidermal water loss was significantly greater at weeks 1, 2, and 3 on the benzoyl peroxide/adapalene–treated side of the face...
Conference Coverage
Weight Contributes to Anti-TNF Response in PsA
Major finding: Minimal disease activity is achieved more often by obese PsA patients who lose at least 5% of their body weight than by those who...
Aesthetic Dermatology
Onion Extract Improved Scars by 36%
Major Finding: An 8-week regimen of an onion extract–based topical gel led to a 36% greater improvement in the overall appearance of new...
Conference Coverage
SEARCH Turns Up More Diabetes in Youth
Major Finding: From 2001 to 2009, the prevalence of type 1 diabetes rose 23% among American youth aged 20 years and younger.
Conference Coverage
Aggressive BP Lowering in Diabetes No Boost to CVD Outcomes
Major Finding: Cardiovascular disease outcomes did not vary between people with diabetes mellitus whose blood pressure was treated to less than...
Conference Coverage
Rapid HbA1c Rise in a Child? Intensify Treatment Fast
Major Finding: Blood glucose increased from 5.7% to 7.3% in children with type 2 diabetes who responded to long-term treatment, but rose from 6.4...
Conference Coverage
Exenatide Bests Glimepiride as a Metformin Add-On
Major Finding: Inadequate glycemic control was reached by 41% of patients on exenatide compared with 54% taking glimepiride, in addition to...